Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Hepatology Communications|July 18, 2024
Retinoic acid generates a beneficial microenvironment for liver progenitor cell activation in acute liver failureSai Wang, Frederik Link, Stefan Munker, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 28, 2023
The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC ActivationSai Wang, Frederik Link, Mei Han, et al.
The American Journal of Pathology|October 11, 2023
Insulin Determines Transforming Growth Factor β Effects on Hepatocyte Nuclear Factor 4α Transcription in HepatocytesRilu Feng, Chenhao Tong, Tao Lin, et al.
JHEP Reports : Innovation in Hepatology|July 10, 2023
Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiencyJan Stindt, Carola Dröge, Elke Lainka, et al.
Gut|October 24, 2024
ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activationFrederik Link, Yujia Li, Jieling Zhao, et al.
The Lancet. Gastroenterology & Hepatology|August 9, 2020
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation studyStephen A Harrison, Vlad Ratziu, Jérôme Boursier, et al.
Biochemical and Biophysical Research Communications|July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effectsAnne Dropmann, Sophie Alex, Katharina Schorn, et al.
The American Journal of Pathology|May 13, 2016
Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine ExpressionZhe Shen, Yan Liu, Bedair Dewidar, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2025
ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signallingYujia Li, Chenjun Huang, Weiguo Fan, et al.
Pageof 5